AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Tsoukas, CM Turner, HM Hatzakis, GE Blake, GP Goodhew, JE Kilby, DLP Kovacs, CM
Citation: Cm. Tsoukas et al., Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptivelytransferred cells, AIDS RES H, 17(10), 2001, pp. 887-900

Authors: Singer, J Thorne, A Khorasheh, S Raboud, JM Wu, AW Salit, I Tsoukas, CM Lemieux, C Shafran, SD
Citation: J. Singer et al., Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010), INT J STD A, 11(4), 2000, pp. 212-219

Authors: Gagnon, RF Tecimer, SN Watters, AK Tsoukas, CM
Citation: Rf. Gagnon et al., Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir, AM J KIDNEY, 36(3), 2000, pp. 507-515

Authors: Gagnon, RF Tecimer, SN Watters, AK Hatzakis, GE Tsoukas, CM
Citation: Rf. Gagnon et al., The natural history of leukocyturia associated with indinavir treatment inHIV plus individuals, AM J NEPHR, 20(6), 2000, pp. 448-454

Authors: O'Neil, WM Gilfix, BM Markoglou, N Di Girolamo, A Tsoukas, CM Wainer, IW
Citation: Wm. O'Neil et al., Genotype and phenotype of cytochrome P-450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome, EUR J CL PH, 56(3), 2000, pp. 231-240

Authors: O'Neil, WM Pezzullo, JC Di Girolamo, A Tsoukas, CM Wainer, IW
Citation: Wm. O'Neil et al., Glucuronidation and sulphation of paracetamol in HIV-positive patients andpatients with AIDS, BR J CL PH, 48(6), 1999, pp. 811-818

Authors: Lesens, O Deschenes, M Steben, M Belanger, G Tsoukas, CM
Citation: O. Lesens et al., Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection, J INFEC DIS, 179(5), 1999, pp. 1254-1258

Authors: Bernard, NF Yannakis, CM Lee, JS Tsoukas, CM
Citation: Nf. Bernard et al., Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons, J INFEC DIS, 179(3), 1999, pp. 538-547
Risultati: 1-8 |